The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl)-6,8-dihydrospiro[cyclopenta[g]quinoline-7,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one ID: ALA1090847
PubChem CID: 46885134
Max Phase: Preclinical
Molecular Formula: C28H22N4O2
Molecular Weight: 446.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1CCc2ccccc2N1Cc1ccc2cc3c(cc2n1)C[C@@]1(C3)C(=O)Nc2ncccc21
Standard InChI: InChI=1S/C28H22N4O2/c33-25-10-8-17-4-1-2-6-24(17)32(25)16-21-9-7-18-12-19-14-28(15-20(19)13-23(18)30-21)22-5-3-11-29-26(22)31-27(28)34/h1-7,9,11-13H,8,10,14-16H2,(H,29,31,34)/t28-/m1/s1
Standard InChI Key: GCWWLFCJNPWAEP-MUUNZHRXSA-N
Molfile:
RDKit 2D
34 40 0 0 0 0 0 0 0 0999 V2000
4.4364 -0.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6835 0.1527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8834 0.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4157 -1.0611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4906 0.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1911 0.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1495 -0.6794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9194 -0.9733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9869 0.3584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5830 1.1333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7229 -0.6115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7550 0.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3012 -0.6799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3911 -1.1268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2554 0.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1271 -0.7495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1700 0.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9019 0.4534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5994 0.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8235 -1.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5568 -0.8172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2537 -1.2601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2185 -2.0869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4806 -2.4685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7868 -2.0234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4749 0.5244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7310 -0.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9607 -0.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8330 -1.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4748 -2.3007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2466 -1.9999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3705 -1.1874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0311 -1.0578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9442 0.5880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27 2 1 0
12 34 1 0
2 3 1 0
34 15 2 0
15 13 1 0
1 3 1 1
14 16 1 0
16 17 1 0
1 28 1 0
7 8 1 0
8 1 1 0
16 20 1 0
17 18 1 0
18 19 1 0
19 21 1 0
1 9 1 0
9 6 1 0
20 21 2 0
11 4 2 0
21 22 1 0
3 10 2 0
22 23 2 0
11 12 1 0
23 24 1 0
4 7 1 0
24 25 2 0
25 20 1 0
17 26 2 0
6 5 1 0
5 12 2 0
27 28 2 0
14 13 1 0
28 29 1 0
6 7 2 0
29 30 2 0
13 33 2 0
30 31 1 0
33 11 1 0
31 32 2 0
32 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 446.51Molecular Weight (Monoisotopic): 446.1743AlogP: 4.10#Rotatable Bonds: 2Polar Surface Area: 75.19Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.75CX Basic pKa: 3.87CX LogP: 4.10CX LogD: 4.10Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -0.49
References 1. Stump CA, Bell IM, Bednar RA, Fay JF, Gallicchio SN, Hershey JC, Jelley R, Kreatsoulas C, Moore EL, Mosser SD, Quigley AG, Roller SA, Salvatore CA, Sharik SS, Theberge CR, Zartman CB, Kane SA, Graham SL, Selnick HG, Vacca JP, Williams TM.. (2010) Identification of potent, highly constrained CGRP receptor antagonists., 20 (8): [PMID:20299218 ] [10.1016/j.bmcl.2010.02.086 ]